Latest News about MDGL
Recent news which mentions MDGL
3 Biotech Stocks That Wall Street Analysts Can’t Get Enough Of
August 30, 2023
From InvestorPlace
The 3 Most Promising Pharma Stocks to Own Now
August 30, 2023
From InvestorPlace
From Motley Fool
Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find It
August 23, 2023
From Motley Fool
From MarketWatch
Ozempic Could Have a New Multibillion-Dollar Market Opportunity. Is Novo Nordisk Stock a No-Brainer Buy?
August 02, 2023
From Motley Fool
Terns Pharmaceuticals Is "Attractively Priced" Despite Pressure From Eli Lilly's Obesity Data, Analyst Says
June 28, 2023
From Benzinga
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 27, 2023
From Benzinga
From MarketWatch
2 Growth Stocks That Doubled in 2023 and Could Shoot 55% to 87% Higher, According to Wall Street
May 30, 2023
From Motley Fool
From Benzinga
From Motley Fool
Why These 3 Nasdaq Stocks Buckled Today
May 16, 2023
From Motley Fool
Viking Therapeutics Outperforms Expectations: Analyst Increases Price Target Following Successful VK2809 Trial
May 16, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
April 28, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 27, 2023
From Benzinga
3 Biotechs That Might Get Bought Out in 2023
April 26, 2023
From Motley Fool
Why Madrigal Pharmaceuticals Stock Gained 20% This Week
April 20, 2023
From Motley Fool
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
April 20, 2023
From Benzinga
5 Best Stocks to Buy in April
April 01, 2023
From Motley Fool
From Motley Fool
Is Viking Therapeutics a Smart Buy on the Dip?
March 27, 2023
From Motley Fool
From InvestorPlace
Tickers
MDGL
From Motley Fool
3 Incredible Growth Stocks to Buy if the Market Dips
March 02, 2023
From Motley Fool
2 Surging Healthcare Stocks That Are Still Worth Buying
February 23, 2023
From Motley Fool
Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval
February 13, 2023
From MarketWatch
3 Top Healthcare Stocks to Buy for January
January 11, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.